
Monique T. Cole
Examiner (ID: 7764)
| Most Active Art Unit | 1743 |
| Art Unit(s) | MPEP, 1721, 1743, 1773, 1797 |
| Total Applications | 786 |
| Issued Applications | 576 |
| Pending Applications | 39 |
| Abandoned Applications | 173 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6601180
[patent_doc_number] => 20100292345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'THERAPEUTIC USES OF CANNABIGEROL'
[patent_app_type] => utility
[patent_app_number] => 12/666385
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3506
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0292/20100292345.pdf
[firstpage_image] =>[orig_patent_app_number] => 12666385
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/666385 | THERAPEUTIC USES OF CANNABIGEROL | Jun 24, 2008 | Abandoned |
Array
(
[id] => 5350020
[patent_doc_number] => 20090005381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/144821
[patent_app_country] => US
[patent_app_date] => 2008-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 32090
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005381.pdf
[firstpage_image] =>[orig_patent_app_number] => 12144821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/144821 | METHODS OF TREATING SEROTONIN-MEDIATED DISEASES AND DISORDERS | Jun 23, 2008 | Abandoned |
Array
(
[id] => 4663182
[patent_doc_number] => 20080254089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'PHARMACEUTICAL PRODUCTS COMPRISING BISPHOSPHONATES'
[patent_app_type] => utility
[patent_app_number] => 12/141676
[patent_app_country] => US
[patent_app_date] => 2008-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6757
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12141676
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/141676 | PHARMACEUTICAL PRODUCTS COMPRISING BISPHOSPHONATES | Jun 17, 2008 | Abandoned |
Array
(
[id] => 4853166
[patent_doc_number] => 20080318909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Use Of Linoleic Compounds Against Heart Failure'
[patent_app_type] => utility
[patent_app_number] => 12/140088
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7069
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318909.pdf
[firstpage_image] =>[orig_patent_app_number] => 12140088
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/140088 | Use Of Linoleic Compounds Against Heart Failure | Jun 15, 2008 | Abandoned |
Array
(
[id] => 5465718
[patent_doc_number] => 20090325918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action'
[patent_app_type] => utility
[patent_app_number] => 12/214352
[patent_app_country] => US
[patent_app_date] => 2008-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4840
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325918.pdf
[firstpage_image] =>[orig_patent_app_number] => 12214352
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/214352 | Synthesis and separation of optically active isomers and cyclopropyl derivatives of spironolactone and their biological action | Jun 15, 2008 | Abandoned |
Array
(
[id] => 6249339
[patent_doc_number] => 20100137373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'PESTICIDAL COMPOSITION COMPRISING A STRIGOLACTONE DERIVATIVE AND AN INSECTICIDE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/452090
[patent_app_country] => US
[patent_app_date] => 2008-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11675
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137373.pdf
[firstpage_image] =>[orig_patent_app_number] => 12452090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452090 | PESTICIDAL COMPOSITION COMPRISING A STRIGOLACTONE DERIVATIVE AND AN INSECTICIDE COMPOUND | Jun 11, 2008 | Abandoned |
Array
(
[id] => 6392662
[patent_doc_number] => 20100303896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => '5BETA, 14BETA-ANDROSTANE DERIVATIVES USEFUL FOR THE TREATMENT OF RESTENOSIS AFTER ANGIOPLASTIC OR ENDOARTHERECTOMY AND DISEASES DUE TO ORGAN FIBROSIS'
[patent_app_type] => utility
[patent_app_number] => 12/602827
[patent_app_country] => US
[patent_app_date] => 2008-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6865
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303896.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602827 | 5BETA, 14BETA-ANDROSTANE DERIVATIVES USEFUL FOR THE TREATMENT OF RESTENOSIS AFTER ANGIOPLASTIC OR ENDOARTHERECTOMY AND DISEASES DUE TO ORGAN FIBROSIS | Jun 3, 2008 | Abandoned |
Array
(
[id] => 4711709
[patent_doc_number] => 20080300235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'FXR Agonists for Reducing LOX-1 Expression'
[patent_app_type] => utility
[patent_app_number] => 12/130322
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16847
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300235.pdf
[firstpage_image] =>[orig_patent_app_number] => 12130322
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/130322 | FXR Agonists for Reducing LOX-1 Expression | May 29, 2008 | Abandoned |
Array
(
[id] => 6625802
[patent_doc_number] => 20100172845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/601494
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13735
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20100172845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601494
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601494 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIAL INFECTIONS | May 28, 2008 | Abandoned |
Array
(
[id] => 5452223
[patent_doc_number] => 20090068260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/129535
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20754
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20090068260.pdf
[firstpage_image] =>[orig_patent_app_number] => 12129535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/129535 | BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION | May 28, 2008 | Abandoned |
Array
(
[id] => 6639121
[patent_doc_number] => 20100174001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'ANTIOXIDANT FOR FOOD'
[patent_app_type] => utility
[patent_app_number] => 12/602231
[patent_app_country] => US
[patent_app_date] => 2008-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5050
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0174/20100174001.pdf
[firstpage_image] =>[orig_patent_app_number] => 12602231
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/602231 | ANTIOXIDANT FOR FOOD | May 5, 2008 | Abandoned |
Array
(
[id] => 4728105
[patent_doc_number] => 20080207649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'METHOD OF TREATING BRAIN ISCHEMIA'
[patent_app_type] => utility
[patent_app_number] => 12/112801
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3446
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207649.pdf
[firstpage_image] =>[orig_patent_app_number] => 12112801
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/112801 | METHOD OF TREATING BRAIN ISCHEMIA | Apr 29, 2008 | Abandoned |
Array
(
[id] => 4814045
[patent_doc_number] => 20080194676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'FORMULATIONS FOR ORAL ADMINISTRATION OF CROMOLYN SODIUM'
[patent_app_type] => utility
[patent_app_number] => 12/103821
[patent_app_country] => US
[patent_app_date] => 2008-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18859
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194676.pdf
[firstpage_image] =>[orig_patent_app_number] => 12103821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/103821 | Formulations for oral administration of cromolyn sodium | Apr 15, 2008 | Issued |
Array
(
[id] => 6494754
[patent_doc_number] => 20100093770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT'
[patent_app_type] => utility
[patent_app_number] => 12/450832
[patent_app_country] => US
[patent_app_date] => 2008-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5329
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093770.pdf
[firstpage_image] =>[orig_patent_app_number] => 12450832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/450832 | THERAPEUTIC AGENT FOR GLAUCOMA CONTAINING ADENOSINE DERIVATIVE AS ACTIVE INGREDIENT | Apr 13, 2008 | Abandoned |
Array
(
[id] => 4682915
[patent_doc_number] => 20080249141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters'
[patent_app_type] => utility
[patent_app_number] => 12/082038
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7719
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249141.pdf
[firstpage_image] =>[orig_patent_app_number] => 12082038
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/082038 | Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters | Apr 6, 2008 | Abandoned |
Array
(
[id] => 4720208
[patent_doc_number] => 20080242731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'TOPICAL ANESTHESIA FORMULATION FOR BODILY CAVITIES'
[patent_app_type] => utility
[patent_app_number] => 12/055172
[patent_app_country] => US
[patent_app_date] => 2008-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5589
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242731.pdf
[firstpage_image] =>[orig_patent_app_number] => 12055172
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/055172 | TOPICAL ANESTHESIA FORMULATION FOR BODILY CAVITIES | Mar 24, 2008 | Abandoned |
Array
(
[id] => 4740583
[patent_doc_number] => 20080234236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'REDUCTION OF ADVERSE EVENTS AFTER PERCUTANEOUS INTERVENTION BY USE OF A THROMBIN RECEPTOR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 12/051504
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 8675
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12051504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/051504 | REDUCTION OF ADVERSE EVENTS AFTER PERCUTANEOUS INTERVENTION BY USE OF A THROMBIN RECEPTOR ANTAGONIST | Mar 18, 2008 | Abandoned |
Array
(
[id] => 5534163
[patent_doc_number] => 20090233951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Parenteral solutions containing metolazone'
[patent_app_type] => utility
[patent_app_number] => 12/077008
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2366
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233951.pdf
[firstpage_image] =>[orig_patent_app_number] => 12077008
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/077008 | Parenteral solutions containing metolazone | Mar 16, 2008 | Issued |
Array
(
[id] => 4823393
[patent_doc_number] => 20080227823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS'
[patent_app_type] => utility
[patent_app_number] => 12/042277
[patent_app_country] => US
[patent_app_date] => 2008-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14423
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227823.pdf
[firstpage_image] =>[orig_patent_app_number] => 12042277
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/042277 | AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Mar 3, 2008 | Abandoned |
Array
(
[id] => 7685220
[patent_doc_number] => 20100120921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'RENIN INHIBITORS FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH HIGH SODIUM DIET'
[patent_app_type] => utility
[patent_app_number] => 12/528187
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11456
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120921.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528187
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528187 | RENIN INHIBITORS FOR TREATMENT OF HYPERTENSION IN PATIENTS WITH HIGH SODIUM DIET | Feb 27, 2008 | Abandoned |